Wu Tsung-Tsong, Minister Without Portfolio of the Republic of China (Taiwan) supervises and coordinates Taiwan’s Biomedical Industry Innovation Program. In this exclusive interview, he documents his main priorities and the government’s unrivalled commitment to further enhancing the attractiveness of Taiwan’s biotech ecosystem and bolstering a win-win relationship between Taiwan, the country’s innovative companies, and the leading multinationals in the sector.
As Executive Yuan’s Minister without Portfolio, could you provide an insight into your main responsibilities regarding the development of Taiwan’s pharmaceutical, biotech, and biomedical sectors?
"Fostering the development of the pharmaceutical and biotech industries holds a central importance within President Tsai’s strategic vision to build Taiwan’s new economic model."
